# Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/addition-of-radium-223-to-abiraterone-acetate-and-prednisone-or-prednisolone-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Matthew R. Smith,Chris Parker,Fred Saad,Kurt Miller,Bertrand Tombal,Quan Sing Ng,Martin Boegemann,Vsevolod Matveev,Josep M. Piulats,Luis Eduardo Rosa Zucca,Oleg Karyakin,Go Kimura,Nobuaki Matsubara,William Carlos Nahas,Franco Nolè,Eli Rosenbaum,Axel Heidenreich,Yoshiyuki Kakehi,Amily Zhang,Heiko Krissel,Michael Teufel,Junwu Shen,Volker Jean Wagner,Celestia S. Higano |
| Citations | 407 |
| DOI | 10.1016/s1470-2045(18)30860-x |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | http://hdl.handle.net/2078.1/213463 |
| OpenAlex ID | https://openalex.org/W2911490798 |
| PMID | 30738780 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Quan Sing Ng](https://scholariq.org/researchers/quan-sing-ng/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

## Paper topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.